Market research services for pharma, healthcare, and commercial industries

KOLAdvisory boardsPathways

Qualitative research & expert insights

In-depth interviews, focus groups, and advisory boards with KOLs, treating physicians, payers, and hospital decision-makers — designed to explain the why behind adoption and access, not just the what.

Market access & HTA strategy

Evidence-led pricing, payer engagement, and value-story testing for the US, EU5, UK, and GCC — with HTA and reimbursement support mapped to NICE, G-BA, HAS, CMS, and Gulf health authority expectations.

HTAPricingGCC access

LandscapeLaunch prepBiosimilars

Competitive intelligence

Competitor monitoring, pipeline and landscape assessments, launch-readiness reviews, and biosimilar impact studies — turned into a clear read on where your brand can realistically win.

FeasibilityRWEInvestigators

Clinical trial support

Site identification, investigator profiling, patient-recruitment feasibility, protocol feedback from treating physicians, and real-world evidence planning across the Americas, Europe, and MENA.

StakeholdersJourney mappingInfluence

KOL & stakeholder mapping

Identification of the opinion leaders, committees, and procurement voices that shape decisions — with ethnographic research, patient-journey mapping, and treatment-pathway analysis where clinical context matters.

Fieldwork & analytics

Methodologies across industries

The same senior team runs CATI, CAWI, and CAPI fieldwork for pharma HCP panels and B2B buyer programmes — plus mystery shopping, price elasticity, focus groups, and online behaviour tracking where your category demands it.

CATI

CATI — telephone interviewing

Computer-assisted telephone interviewing for hard-to-reach B2B buyers, HCP panels, and senior decision-makers — with live supervision, quota management, and bilingual Arabic–English field teams across MENA.

Pharma · B2B · Financial services

CAWI

CAWI — online surveys

Computer-assisted web interviewing at scale — physician trackers, brand health, employee pulse, and consumer panels with mobile-first design, fraud screening, and multi-country harmonisation.

All industries · Global panels

CAPI

CAPI — face-to-face fieldwork

Computer-assisted personal interviewing for hospital audits, retail audits, and on-site B2B interviews — with offline-capable devices, GPS verification, and supervisor QC in GCC, LATAM, and Europe.

Healthcare · Retail · FMCG

Focus groups & mini-groups

Moderated group discussions — in-person, virtual, or hybrid — for concept testing, message refinement, and category exploration with simultaneous translation in Arabic, French, German, and Portuguese.

Pharma · B2C · Tourism

Mystery shopping & audit programmes

Structured mystery shopper and service-audit programmes for banking branches, hospitality, retail, and healthcare front-of-house — scored against your service standards with photo and audio evidence where permitted.

Banking · Retail · Hospitality

Price elasticity & conjoint

Van Westendorp, Gabor-Granger, and discrete choice experiments (DCE) to model price sensitivity, pack-size trade-offs, and willingness-to-pay — for pharma launches, FMCG, and financial product pricing.

Pharma · FMCG · Insurance

Online behaviour tracking

Digital journey analysis, click-stream studies, and passive metering modules — combined with survey data to connect stated preference with observed behaviour across e-commerce, banking, and health portals.

B2C · E-commerce · Health-tech

Brand tracking & awareness

Continuous or pulse trackers for aided and unaided awareness, consideration, NPS, and competitive share-of-voice — fielded CAWI or CATI with dashboards your marketing team can act on weekly.

FMCG · Telecom · Pharma OTC

Segmentation & MaxDiff

Needs-based segmentation, latent class analysis, and MaxDiff prioritisation to rank features, messages, or product attributes — feeding targeting and portfolio decisions in B2B and B2C categories.

B2B · Technology · Consumer

Commercial & cross-industry research

Non-pharma programmes for enterprise buyers, institutional decision-makers, and consumer markets — Americas, EMEA, Africa, and LATAM.

Pharma, biotech & MedTech

The discipline BioNixus was founded on — drug launch, market access, MedTech, diagnostics, biotech, and consumer health evidence with the sampling and compliance standards regulated categories require.

Oncology · rare disease · devices · OTC · vaccines

B2B & enterprise research

Buyer-committee mapping, market sizing, and competitive intelligence for technology, energy, real estate, public sector, education, and industrial manufacturing — including wood products and engineered materials.

Technology · real estate · energy · manufacturing

B2C & consumer research

Brand tracking, shopper insight, segmentation, and demand studies for FMCG, retail, financial services, telecom, automotive, hospitality, and tourism — where mass-market behaviour drives the decision.

Banking · retail · tourism · FMCG · telecom

AI, IT & growth-stage ventures

Win-loss analysis, buyer persona research, and GTM validation for B2B software, cybersecurity, health-tech AI, and IT services — combining enterprise buyer depth with the speed growth teams need.

SaaS · AI startups · IT services · health-tech